Elaia is a Paris-headquartered European technology and deep-tech investor. Its current DTS3 and DV5 strategies cover B2B companies from pre-seed through Series B across computing, life sciences and industrial innovation.
At a glance
Investment focus
Source and review
Profile reviewed on . Research reviewed by the EverythingVC Editorial Team.
European mandate
- Geographic fit
- European technology and deep-tech founders from inception
- Round behaviour
- Strategy-specific early-stage investor from pre-seed through Series B
Founder fit
- Strongest documented fit
- Relevant to European B2B technology and deep-tech founders from pre-seed through Series B. Current vehicles include DTS3 for pre-seed and seed companies in computing, life sciences and industrial innovation, and DV5 for broader early-stage breakthrough technology with EUR 1 million to EUR 15 million tickets.
- Limits and questions to verify
- Elaia operates multiple strategies, so a platform-wide stage range does not identify the right fund. DTS3 is specifically deep-tech, B2B and research-connected, while DV5 has a broader early-stage remit and its own ticket and maturity expectations.
- Active-fund and deployment evidence
- Elaia's March 2026 DTS3 final close and February 2026 DV5 first close document active capital, European geography, stages, sectors and cheque ranges for the firm's two current strategies.
